100 related articles for article (PubMed ID: 15051890)
1. Germ-line expression of an oncogenic erbB2 allele confers resistance to erbB2-induced mammary tumorigenesis.
Andrechek ER; Hardy WR; Laing MA; Muller WJ
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4984-9. PubMed ID: 15051890
[TBL] [Abstract][Full Text] [Related]
2. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
3. p27Kip1 repression of ErbB2-induced mammary tumor growth in transgenic mice involves Skp2 and Wnt/beta-catenin signaling.
Hulit J; Lee RJ; Li Z; Wang C; Katiyar S; Yang J; Quong AA; Wu K; Albanese C; Russell R; Di Vizio D; Koff A; Thummala S; Zhang H; Harrell J; Sun H; Muller WJ; Inghirami G; Lisanti MP; Pestell RG
Cancer Res; 2006 Sep; 66(17):8529-41. PubMed ID: 16951165
[TBL] [Abstract][Full Text] [Related]
4. Rassf3 is responsible in part for resistance to mammary tumor development in neu transgenic mice.
Jacquemart IC; Springs AE; Chen WY
Int J Oncol; 2009 Feb; 34(2):517-28. PubMed ID: 19148488
[TBL] [Abstract][Full Text] [Related]
5. Formation of Neu/ErbB2-induced mammary tumors is unaffected by loss of ErbB4.
Jackson-Fisher AJ; Bellinger G; Shum E; Duong JK; Perkins AS; Gassmann M; Muller W; Kent Lloyd KC; Stern DF
Oncogene; 2006 Sep; 25(41):5664-72. PubMed ID: 16652155
[TBL] [Abstract][Full Text] [Related]
6. Stat3 is required for anchorage-independent growth and metastasis but not for mammary tumor development downstream of the ErbB-2 oncogene.
Barbieri I; Quaglino E; Maritano D; Pannellini T; Riera L; Cavallo F; Forni G; Musiani P; Chiarle R; Poli V
Mol Carcinog; 2010 Feb; 49(2):114-20. PubMed ID: 20027636
[TBL] [Abstract][Full Text] [Related]
7. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis.
Vaillant F; Asselin-Labat ML; Shackleton M; Forrest NC; Lindeman GJ; Visvader JE
Cancer Res; 2008 Oct; 68(19):7711-7. PubMed ID: 18829523
[TBL] [Abstract][Full Text] [Related]
8. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
9. Mouse mammary tumor virus p75 and p110 CUX1 transgenic mice develop mammary tumors of various histologic types.
Cadieux C; Kedinger V; Yao L; Vadnais C; Drossos M; Paquet M; Nepveu A
Cancer Res; 2009 Sep; 69(18):7188-97. PubMed ID: 19738070
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of DecR1 impairs ErbB2/Neu-induced mammary tumor development.
Ursini-Siegel J; Rajput AB; Lu H; Sanguin-Gendreau V; Zuo D; Papavasiliou V; Lavoie C; Turpin J; Cianflone K; Huntsman DG; Muller WJ
Mol Cell Biol; 2007 Sep; 27(18):6361-71. PubMed ID: 17636013
[TBL] [Abstract][Full Text] [Related]
11. Developmental timing of activated erbB2 expression plays a critical role in the induction of mammary tumors.
Andrechek ER; Muller WJ
Cell Cycle; 2004 Sep; 3(9):1111-3. PubMed ID: 15326381
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility loci affecting ERBB2/neu-induced mammary tumorigenesis in mice.
Quan L; Dittmar A; Zhou Y; Hutson A; Stassen AP; Demant P
Genes Chromosomes Cancer; 2012 Jul; 51(7):631-43. PubMed ID: 22419448
[TBL] [Abstract][Full Text] [Related]
13. Loss of the 14-3-3σ tumor suppressor is a critical event in ErbB2-mediated tumor progression.
Ling C; Su VM; Zuo D; Muller WJ
Cancer Discov; 2012 Jan; 2(1):68-81. PubMed ID: 22585169
[TBL] [Abstract][Full Text] [Related]
14. Mammary development and tumorigenesis in mice expressing a truncated human Notch4/Int3 intracellular domain (h-Int3sh).
Raafat A; Bargo S; Anver MR; Callahan R
Oncogene; 2004 Dec; 23(58):9401-7. PubMed ID: 15531924
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers.
Andrechek ER; Laing MA; Girgis-Gabardo AA; Siegel PM; Cardiff RD; Muller WJ
Cancer Res; 2003 Aug; 63(16):4920-6. PubMed ID: 12941816
[TBL] [Abstract][Full Text] [Related]
16. Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis.
Julien SG; Dubé N; Read M; Penney J; Paquet M; Han Y; Kennedy BP; Muller WJ; Tremblay ML
Nat Genet; 2007 Mar; 39(3):338-46. PubMed ID: 17259984
[TBL] [Abstract][Full Text] [Related]
17. Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands.
Wang L; Bhattacharyya N; Rabi T; Wang L; Banerjee S
Carcinogenesis; 2007 Jun; 28(6):1356-63. PubMed ID: 17166880
[TBL] [Abstract][Full Text] [Related]
18. Ets2-dependent microenvironmental support of mouse mammary tumors.
Tynan JA; Wen F; Muller WJ; Oshima RG
Oncogene; 2005 Oct; 24(46):6870-6. PubMed ID: 16007139
[TBL] [Abstract][Full Text] [Related]
19. Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
Sarkisian CJ; Keister BA; Stairs DB; Boxer RB; Moody SE; Chodosh LA
Nat Cell Biol; 2007 May; 9(5):493-505. PubMed ID: 17450133
[TBL] [Abstract][Full Text] [Related]
20. Transcriptome characterization of human mammary cell lines expressing different levels of ERBB2 by serial analysis of gene expression.
dos Santos ML; Palanch CG; Salaorni S; Da Silva WA; Nagai MA
Int J Oncol; 2006 Jun; 28(6):1441-61. PubMed ID: 16685446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
